This site is intended for healthcare professionals
News

FDA approves supplemental indication of Spravato for major depressive disorder with acute suicidal ideation or behavior. Johnson & Johnson

Read time: 1 mins
Last updated:10th Aug 2020
Published:9th Aug 2020
Condition: Depression
Type: drug
Register free for full access to medthority.com